Cellectar Biosciences, Inc. Quarterly Common Stock, Shares, Issued from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Cellectar Biosciences, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q3 2024.
  • Cellectar Biosciences, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 40.6M shares, a 309% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 40.6M +30.6M +309% Sep 30, 2024 10-Q 2024-11-18
Q2 2024 35.8M +26.1M +268% Jun 30, 2024 10-Q 2024-10-29
Q1 2024 33.2M +23.4M +240% Mar 31, 2024 10-Q/A 2024-10-29
Q4 2023 20.7M +11.4M +121% Dec 31, 2023 10-Q 2024-11-18
Q3 2023 9.92M +3.81M +62.3% Sep 30, 2023 10-K/A 2024-10-29
Q2 2023 9.74M +3.63M +59.4% Jun 30, 2023 10-K/A 2024-10-29
Q1 2023 9.74M +3.63M +59.4% Mar 31, 2023 10-K/A 2024-10-29
Q4 2022 9.39M +3.28M +53.6% Dec 31, 2022 10-K/A 2024-10-29
Q3 2022 6.11M -55M -90% Sep 30, 2022 10-K/A 2024-10-29
Q2 2022 6.11M -49.2M -88.9% Jun 30, 2022 10-K/A 2024-10-29
Q1 2022 6.11M -46.6M -88.4% Mar 31, 2022 10-K/A 2024-10-29
Q4 2021 6.11M -39.3M -86.6% Dec 31, 2021 10-K 2023-03-09
Q3 2021 61.1M +34.3M +128% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 55.3M +29.8M +117% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 52.7M +43.3M +461% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 45.4M +36.1M +384% Dec 31, 2020 10-K 2022-03-21
Q3 2020 26.8M +17.4M +186% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 25.5M +16.1M +171% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 9.4M +4.31M +84.7% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 9.39M +4.65M +98.4% Dec 31, 2019 10-K 2021-03-02
Q3 2019 9.39M +5.12M +120% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 9.39M +7.61M +429% Jun 30, 2019 10-Q 2019-08-12
Q1 2019 5.09M -12M -70.3% Mar 31, 2019 10-Q 2019-05-06
Q4 2018 4.73M +3.07M +184% Dec 31, 2018 10-K 2020-03-09
Q3 2018 4.27M -9.21M -68.3% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 1.77M -11.7M -86.8% Jun 30, 2018 10-Q 2018-08-10
Q1 2018 17.1M +3.64M +27.1% Mar 31, 2018 10-Q 2018-05-11
Q4 2017 1.67M -8.7M -83.9% Dec 31, 2017 10-K 2019-02-26
Q3 2017 13.5M +8.11M +151% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 13.5M +8.09M +151% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 13.5M +12.6M +1469% Mar 31, 2017 10-Q 2017-05-11
Q4 2016 10.4M +90 +0% Dec 31, 2016 10-K 2018-03-21
Q3 2016 5.37M -2.2M -29% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 5.37M -2.19M -29% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 858K -6.7M -88.7% Mar 31, 2016 10-Q 2016-05-12
Q4 2015 10.4M +9.61M +1271% Dec 31, 2015 10-K 2017-03-15
Q3 2015 7.56M +1.37K +0.02% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 7.56M +4.69M +164% Jun 30, 2015 10-Q 2015-08-12
Q1 2015 7.56M -49.8M -86.8% Mar 31, 2015 10-Q 2015-05-20
Q4 2014 756K -2.11M -73.6% Dec 31, 2014 10-K/A 2016-10-20
Q3 2014 7.56M -49.8M -86.8% Sep 30, 2014 10-Q/A 2015-05-20
Q2 2014 2.87M -54.5M -95% Jun 30, 2014 10-Q 2014-08-04
Q1 2014 57.4M 0 0% Mar 31, 2014 10-Q 2014-05-14
Q4 2013 2.87M -43.5M -93.8% Dec 31, 2013 10-K/A 2015-05-20
Q3 2013 57.4M +13.9M +32.1% Sep 30, 2013 10-Q 2013-11-13
Q2 2013 57.4M +14.2M +32.9% Jun 30, 2013 10-Q 2013-08-12
Q1 2013 57.4M +20.4M +55.3% Mar 31, 2013 10-Q 2013-05-15
Q4 2012 46.4M +9.49M +25.7% Dec 31, 2012 10-K 2014-03-19
Q3 2012 43.5M +16.6M +62% Sep 30, 2012 10-Q 2012-11-06
Q2 2012 43.2M +16.4M +61% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 37M Mar 31, 2012 10-Q 2012-05-04
Q4 2011 36.9M +24.1M +188% Dec 31, 2011 10-K 2013-03-28
Q3 2011 26.8M Sep 30, 2011 10-Q 2011-11-07
Q2 2011 26.8M Jun 30, 2011 10-Q 2011-08-12
Q4 2010 12.8M Dec 31, 2010 10-K 2012-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.